PEPINO: Cost-utility Analysis of the Use of the Paro Robotic Seal by Elderly Patients With Moderate or Severe Cognitive Disorders in Institutions: a Randomised Study.

Sponsor
Centre Hospitalier Departemental Vendee (Other)
Overall Status
Recruiting
CT.gov ID
NCT04941222
Collaborator
(none)
136
1
2
22
6.2

Study Details

Study Description

Brief Summary

Many residents from establishments for dependent elderly people (EHPAD) have memory disorders with behavioural problems such as agitation, aggression and anxiety, which make it difficult to assist them on a daily basis.

Studies have proven the beneficial effect of the therapeutic seal robot PARO® in behavioural disorders. The present project aims to complement these data with a medico-economic study. At present, the only study of this type has been carried out in Australia, and is not transposable to France.

Condition or Disease Intervention/Treatment Phase
  • Other: With robotic seal "PARO"
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
136 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Cost-utility Analysis of the Use of the Paro Robotic Seal by Elderly Patients With Moderate or Severe Cognitive Disorders in Institutions: a Randomised Study.
Actual Study Start Date :
Jul 29, 2021
Anticipated Primary Completion Date :
May 29, 2023
Anticipated Study Completion Date :
May 29, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: With robotic seal "PARO"

The robot will be made available to the patient by the caregiver in charge of the patient for 5 minutes before a toilet and for the duration of the treatment (about 10 minutes), twice a week for 16 weeks.

Other: With robotic seal "PARO"
The PARO robot will be made available to the patient by the caregiver in charge of the patient for 5mn before a toilet and during the duration of the care (about 10mn), at the frequency of twice a week for 16 weeks

No Intervention: Without robotic seal "PARO"

The care of the patient during the toilet will be carried out according to the modalities currently in use in the facility.

Outcome Measures

Primary Outcome Measures

  1. Incremental cost-utility ratio [16 weeks after implementation of toilets with/without PARO]

    Incremental cost-utility ratio (cost/QALY) from a societal perspective and a time horizon of 16 weeks of the use of the PARO robot

Eligibility Criteria

Criteria

Ages Eligible for Study:
70 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients over 70 years of age

  • With moderate or severe neurocognitive disorders of any etiology (Mini Mental State Examination (MMSE) less than or equal to 20, or not feasible)

  • Resident in EHPAD (establishment for dependent elderly people) or USLD (long-term care unit ) in permanent accommodation for more than 1 month at inclusion

Exclusion Criteria:
  • Patient with presumed life expectancy of less than 3 months

  • Mini Mental State Examination (MMSE) not feasible for any reason other than cognitive impairment (e.g. stroke aphasia), without dementia

  • Known carrier of multi-drug resistant bacteria

  • Carrier of Pace-maker (precautionary advice from manufacturer)

  • Refusal to participate to the study (trusted person, guardian or curator or patient depending on the patient's mental state)

  • Patient under court protection

  • Prior inclusion in an interventional study that may alter the interpretation of the results of the analysis

  • Patient not affiliated to a social security system or beneficiary of such a system

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHD Vendee La Roche-sur-Yon France 85925

Sponsors and Collaborators

  • Centre Hospitalier Departemental Vendee

Investigators

  • Principal Investigator: stéphanie CHENEAU, CHD Vendée

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Departemental Vendee
ClinicalTrials.gov Identifier:
NCT04941222
Other Study ID Numbers:
  • CHD187-19
First Posted:
Jun 28, 2021
Last Update Posted:
Mar 14, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Departemental Vendee
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 14, 2022